Puleco: The 2.65 billion idling funds raised were managed to maturity, and the principal of 8.21 billion was recovered with a profit of 3.6653 million.

In August-September 2024, after deliberation, Plaeco Biotechnology Co., Ltd. plans to temporarily manage up to 265 million RMB of idle raised funds through cash management, with a validity period of 12 months from the date of approval by the third extraordinary shareholders' meeting in 2024. On August 22, 2025, the company will redeem all the idle raised funds managed in cash, and return them to the designated account.